Company profile
ACM Biolabs company profile
ACM Biolabs focuses on developing novel vaccines and antibodies using proprietary artificial cell membrane ("ACM") technology. ACM is able to incorporate functional, folded membrane proteins into the artificial cell membranes which keeps them stable, allowing them to induce a strong immune reaction. ACM has demonstrated efficacy via both injected and oral dosages using synthesized membrane proteins and has a growing pipeline of vaccines and antibodies. The company is headquartered in Singapore, and has been operational since 2013.
Business identity
- Website
- https://www.acmbiolabs.com
- Contact email
- [email protected]
- Phone number
- +65 6265 5646
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2013-01-01, Year
Headquarters
- Headquarters
- Slite, Gotland, Sweden
- Postal code
- 638075
- Country code
- SE
- Continent
- Europe